All In MedTech

Device Trial Radar · NCT05383651

Post Market, Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator

International Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator and the IFLow Sensor During Routine Use in the Neonatal, Pediatric, and Adult Intensive Care Unit

Last checked: Nov 20, 2026Latest source record: Sep 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

350

Actual

Start

Feb 1, 2023

Primary completion

May 31, 2024

Study completion Jun 30, 2024

Sponsor

Lead sponsor
Vyaire MedicalNot on our public-company list
Sponsor type
Industry
First posted
May 20, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 6 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective post market clinical follow up (PMCF) study will evaluate the safety and performance of bellavista ventilator and the iFlow sensors in daily clinical routine.

Conditions

  • Ventilation Therapy; Complications

Interventions

  • bellavista 1000Device

    observational use of Bellavista 1000 ventilator in adult ventilated patients

  • bellavista 1000 neoDevice

    observational use of Bellavista 1000 ventilator in neonatal ventilated patients

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ventilator Performance - Relationship between the set and observed Positive End-Expiratory Pressure (PEEP)Time frame: through study completion, an average of 12 hours- 24 days

4 more outcomes with a free account

Locations

2 sites in 2 countries. Site status is shown where the registry gives one.

  • University Health Network

    Toronto, Ontario, Canada

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.